Cargando…

PF-06649751 efficacy and safety in early Parkinson’s disease: a randomized, placebo-controlled trial

BACKGROUND: PF-06649751 is a novel, oral, non-catechol-based, D1/D5 dopamine receptor partial agonist under investigation for the treatment of motor symptoms associated with Parkinson’s disease. METHODS: A 15-week, phase II, double-blind, placebo-controlled clinical trial was conducted to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riesenberg, Robert, Werth, John, Zhang, Yao, Duvvuri, Sridhar, Gray, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066585/ https://www.ncbi.nlm.nih.gov/pubmed/32201505 http://dx.doi.org/10.1177/1756286420911296

Ejemplares similares

Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated
por: Sohur, U. Shivraj, et al.
Publicado: (2018)

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer’s disease
por: Delnomdedieu, Marielle, et al.
Publicado: (2016)

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials
por: Ostrowitzki, Susanne, et al.
Publicado: (2022)

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
por: Brown, David, et al.
Publicado: (2019)

Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
por: Zhang, Zhenxin, et al.
Publicado: (2018)

Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics
por: Mastrandrea, Lucy D., et al.
Publicado: (2019)

Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients: Protocol for a randomized, double-blind, placebo-controlled trial
por: Shi, Jing, et al.
Publicado: (2017)

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis
por: Spiera, Robert, et al.
Publicado: (2020)

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
por: Zhao, Ying, et al.
Publicado: (2021)

Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials
por: Hasegawa, Kazuko, et al.
Publicado: (2021)

Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial
por: Davidescu, Lavinia, et al.
Publicado: (2022)

Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
por: Campillo, Jérémy T, et al.
Publicado: (2021)

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
por: Roufosse, Florence, et al.
Publicado: (2020)

Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study
por: Singh, Ravi Shankar P., et al.
Publicado: (2020)

Efficacy and safety of rotigotine in elderly patients with Parkinson’s disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials
por: Nomoto, Masahiro, et al.
Publicado: (2017)

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
por: Tobback, Els, et al.
Publicado: (2022)

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
por: Mizuno, Yoshikuni, et al.
Publicado: (2017)

Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials
por: Meng, Fanqiang, et al.
Publicado: (2022)

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial
por: Biglan, Kevin, et al.
Publicado: (2021)

Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials
por: Zhao, Mingjun, et al.
Publicado: (2022)

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial
por: Kimball, Alexa B., et al.
Publicado: (2023)

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease
por: Marrinan, Sarah L., et al.
Publicado: (2017)

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial
por: Ayers, Catherine R., et al.
Publicado: (2019)

Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial
por: Grilo, Carlos M., et al.
Publicado: (2021)

Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
por: Olotu, Ally, et al.
Publicado: (2018)

Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
por: Goldman, Robert, et al.
Publicado: (2017)

Efficacy and Safety of Placebo During the Maintenance Therapy of Ovarian Cancer in Randomized Controlled Trials: A Systematic Review and Meta-analysis
por: Wang, Jin-feng, et al.
Publicado: (2022)

Efficacy, Safety, and Tolerability of Three Regimens for Prevention of Malaria: A Randomized, Placebo-Controlled Trial in Ugandan Schoolchildren
por: Nankabirwa, Joaniter, et al.
Publicado: (2010)

Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials
por: Karbasi-Afshar, Reza, et al.
Publicado: (2014)

Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2015)

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial
por: Upadhyaya, Himanshu P., et al.
Publicado: (2019)

In Vitro and Randomized, Double‐Blind, Placebo‐Controlled Trial to Determine the Efficacy and Safety of Nine Antiacne Medicinal Plants
por: Said, Omar, et al.
Publicado: (2020)

Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial
por: Salehifar, Ebrahim, et al.
Publicado: (2020)

Efficacy and safety of fermented oyster extract for height of children with short stature: a randomized placebo-controlled trial
por: Jeong, Aram, et al.
Publicado: (2021)

Efficacy and Safety of Lactobacillus reuteri CCFM1040 in Allergic Rhinitis and Asthma: A Randomized, Placebo-Controlled Trial
por: Li, Lingzhi, et al.
Publicado: (2022)

Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Li, Yi-Fan, et al.
Publicado: (2021)

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection
por: Murphy, Sean C., et al.
Publicado: (2021)

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension
por: Aman, Michael G., et al.
Publicado: (2017)

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials
por: Mâsse, Benoît R, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dppmjja9gdbuqe75vbcbomjbu7